FDA
approval
· 2024-05-13
FDA Approved: NOREPINEPHRINE BITARTRATE — Original Application (Rising Pharma Holdings, Inc.)
Summary
FDA approved a generic norepinephrine bitartrate injection under an original ANDA from Rising Pharma Holdings, Inc. for use in the management of acute hypotensi…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for NOREPINEPHRINE BITARTRATE (NOREPINEPHRINE BITARTRATE)